A

An Phat Bioplastics JSC
VN:AAA

Watchlist Manager
An Phat Bioplastics JSC
VN:AAA
Watchlist
Price: 8 360 VND -0.48% Market Closed
Market Cap: 3.2T VND
Have any thoughts about
An Phat Bioplastics JSC?
Write Note

Balance Sheet

Balance Sheet Decomposition
An Phat Bioplastics JSC

Current Assets 7T
Cash & Short-Term Investments 3.3T
Receivables 1.8T
Other Current Assets 1.9T
Non-Current Assets 6.1T
Long-Term Investments 1.6T
PP&E 3T
Intangibles 191.4B
Other Non-Current Assets 1.3T
Current Liabilities 4.1T
Accounts Payable 701.3B
Accrued Liabilities 215.9B
Short-Term Debt 2.2T
Other Current Liabilities 987.5B
Non-Current Liabilities 3.8T
Long-Term Debt 780B
Other Non-Current Liabilities 3.1T

Balance Sheet
An Phat Bioplastics JSC

Rotate your device to view
Balance Sheet
Currency: VND
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
336 808
470 062
406 677
509 578
645 475
291 675
963 717
1 988 171
1 642 978
2 435 058
Cash
122 985
242 393
121 150
120 810
217 635
233 349
237 314
1 156 983
1 228 629
1 298 775
Cash Equivalents
213 823
227 669
285 527
388 768
427 840
58 325
726 403
831 187
414 349
1 136 283
Short-Term Investments
30 000
0
0
50 000
720 906
1 251 822
758 600
436 156
448 656
1 079 610
Total Receivables
177 191
203 363
299 088
701 689
1 207 592
1 542 394
1 005 192
1 537 616
1 518 103
1 029 912
Accounts Receivables
122 324
103 201
220 527
417 516
691 607
726 709
587 821
1 125 735
1 007 772
661 884
Other Receivables
54 867
100 161
78 561
284 173
515 985
815 685
417 371
411 881
510 331
368 028
Inventory
137 522
214 187
450 591
536 682
862 749
1 221 503
946 809
997 385
1 790 091
781 680
Other Current Assets
12 859
183 950
205 291
344 768
552 647
663 970
821 732
395 283
258 930
355 320
Total Current Assets
694 379
1 071 561
1 361 646
2 142 717
3 989 369
4 971 364
4 496 051
5 354 611
5 658 759
5 681 580
PP&E Net
646 876
786 535
1 553 477
2 301 095
3 321 830
2 292 933
2 606 515
2 875 596
2 693 451
2 160 412
PP&E Gross
646 876
786 535
1 553 477
2 301 095
3 321 830
2 292 933
2 606 515
2 875 596
2 693 451
2 160 412
Accumulated Depreciation
232 761
305 924
364 892
504 462
744 551
983 460
1 232 888
1 460 375
1 706 991
1 961 659
Intangible Assets
33 093
41 157
95 800
96 512
84 986
81 951
79 742
78 420
77 426
149 114
Goodwill
0
0
0
0
0
0
15 192
36 551
32 470
47 799
Note Receivable
0
0
0
0
21 384
96 367
173 911
278 966
66 843
82 297
Long-Term Investments
39 205
42 587
44 339
0
48 380
346 376
935 927
1 096 257
1 991 257
2 646 104
Other Long-Term Assets
8 097
12 925
22 353
35 833
63 217
198 464
262 077
289 126
275 626
816 138
Other Assets
0
0
0
0
0
0
15 192
36 551
32 470
47 799
Total Assets
1 421 651
N/A
1 954 765
+37%
3 077 616
+57%
4 576 157
+49%
7 529 167
+65%
7 987 454
+6%
8 569 414
+7%
10 009 527
+17%
10 795 833
+8%
11 583 446
+7%
Liabilities
Accounts Payable
160 689
200 886
304 264
519 298
622 779
604 445
542 480
609 835
754 558
517 382
Accrued Liabilities
7 987
5 519
11 293
19 757
29 211
59 857
54 664
73 121
89 989
172 338
Short-Term Debt
0
0
0
0
2 492 407
2 394 539
2 262 590
2 126 277
1 621 225
1 922 724
Current Portion of Long-Term Debt
329 022
438 770
800 795
1 417 686
0
5 548
680 769
56 904
266 596
702 769
Other Current Liabilities
9 976
21 904
23 933
34 062
61 707
172 256
232 333
416 203
474 115
421 828
Total Current Liabilities
507 674
667 079
1 140 285
1 990 804
3 206 103
3 236 646
3 772 835
3 282 339
3 206 483
3 737 041
Long-Term Debt
127 651
468 200
982 579
959 927
1 342 804
1 371 510
617 147
1 175 998
1 242 369
358 857
Deferred Income Tax
0
0
0
457
9
22 387
22 197
0
0
12 439
Minority Interest
9 389
9 922
10 861
248 117
399 364
328 341
426 375
659 891
651 298
619 705
Other Liabilities
0
0
0
0
0
101 673
133 274
96 808
175 796
1 511 238
Total Liabilities
644 714
N/A
1 145 201
+78%
2 133 725
+86%
3 199 304
+50%
4 948 281
+55%
5 060 557
+2%
4 971 827
-2%
5 215 036
+5%
5 275 945
+1%
6 239 280
+18%
Equity
Common Stock
396 000
495 000
569 650
836 000
1 712 000
1 712 000
2 217 600
3 264 345
3 822 745
3 822 745
Retained Earnings
187 993
116 439
161 862
283 770
265 860
602 686
568 717
706 494
721 688
562 623
Additional Paid In Capital
147 502
147 409
160 721
198 064
532 113
532 113
692 074
712 591
823 946
823 946
Other Equity
45 443
50 716
51 658
59 020
70 913
80 098
119 197
111 061
151 508
134 852
Total Equity
776 937
N/A
809 563
+4%
943 891
+17%
1 376 853
+46%
2 580 886
+87%
2 926 897
+13%
3 597 587
+23%
4 794 491
+33%
5 519 887
+15%
5 344 166
-3%
Total Liabilities & Equity
1 421 651
N/A
1 954 765
+37%
3 077 616
+57%
4 576 157
+49%
7 529 167
+65%
7 987 454
+6%
8 569 414
+7%
10 009 527
+17%
10 795 833
+8%
11 583 446
+7%
Shares Outstanding
Common Shares Outstanding
64
67
85
125
198
198
244
326
382
382

See Also

Discover More